Lactobacillus Casei Strain Shirota Fermented Milk for Alleviating Hard Stools in Vietnam

Yakult

Status

Completed

Conditions

Constipation

Treatments

Dietary Supplement: Lactobacillus casei strain Shirota fermented milk

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT05982743

YAK-VN-001

Details and patient eligibility

About

The objective of this study is to provide evidence supporting the efficacy of fermented milk containing Lactobacillus casei strain Shirota in alleviating hard or lumpy stools. A randomized, controlled trial has been designed on constipated adults with a high prevalence of hard stools in Vietnam.

Enrollment

51 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Female or male, aged between 18 to 60 years.
Aware of producing hard or lumpy stools (BS score of 1 or 2) frequently.
Produce hard or lumpy stools (BS score of 1 or 2) ≥ 25% of bowel movements during 2 weeks of screening period.
Voluntarily provide written informed consent to participate in the study.

Exclusion criteria

Subjects whose constipation symptoms are caused by primary organic disease of the colon or pelvic floora or which, in the Investigator's opinion, is caused by medication (e.g. morphine, codeine).
Subjects with metabolic disorders, neurological disorders or any significant diseases or concomitant condition (e.g. abdominal/gastrointestinal surgery) that, in the investigator's opinion, would interfere with participation in the study.
Subjects with any known allergic reactions to any ingredients of milk.
Pregnant or nursing (breast-feeding) women.
Subjects who are unable to refrain from or anticipate the use of any medication (including laxatives, diuretics, prescription and non-prescription drugs, vitamins and herbal supplements), except for paracetamol, oral contraceptives, or hormonal replacement therapy from 2-week before the initiation of screening of subject BS score to the end of the study.
Subjects who are unable to refrain from or anticipate the use of any probiotics, prebiotics or yogurts from 2-week before the initiation of screening of subject BS score to the end of the study.
Participation in another study with Investigational product within 2 months prior to this study.
Drug or alcohol abuse.